GAO, FDA Spar Over Progress On Drug Shortages

Law360, New York (February 10, 2014, 6:55 PM EST) -- The U.S. Government Accountability Office on Monday painted a less rosy portrait of the nation’s progress curbing drug shortages than the U.S. Food and Drug Administration offered just a few days earlier, differing sharply in its assessment of long-term scarcities.

In its report, which was released in conjunction with a hearing on Capitol Hill, the GAO credited regulators for averting many new shortages but argued that the overall number of shortages remains stubbornly high. At least 288 long-term shortages occurred in 2013, compared with just 56...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.